Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.
Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRemoved non-core items: the term 'Interstitial lung disease 2' and the Genetics and Rare Diseases Information Center resource link. These deletions do not affect the study's main data, eligibility criteria, or reported results.SummaryDifference0.2%
- Check18 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0, indicating an update to the document set.SummaryDifference0.1%
- Check25 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%
- Check53 days agoChange DetectedRevision: v3.4.2 was added and a prior government funding notice along with Revision: v3.4.1 were removed; these are system-level updates and do not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check60 days agoChange DetectedA site-wide funding-status notice was added and the page revision was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check68 days agoChange DetectedResults were posted for NCT02503657 with a 2026-01-23 date, including primary and secondary outcomes and safety/tolerability data for MN-001 in IPF. The update adds detailed results and study plan information, replacing prior results-submission notes and enhancing the page's core trial content.SummaryDifference4%
Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.